Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rhabdoid Tumor × Panobinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 11 Recurrence 7 Lymphoma, Large B-Cell, Diffuse 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Sezary Syndrome 2 Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Immunoblastic Lymphadenopathy 2 Colorectal Neoplasms 2 Thyroid Neoplasms 1 Thyroid Diseases 1 Stomach Neoplasms 1 Somatostatinoma 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 X-Rays 6 Phantoms, Imaging 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Cyclophosphamide 4 Biopsy 4 palbociclib 3 Topotecan 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 olaparib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Vemurafenib 2 LY3023414 2 Etoposide 2 selinexor 1 cabozantinib 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Vincristine 1 Temozolomide 1 Stem Cell Transplantation 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04897880 2025-02-24

NORTH

Australian & New Zealand Children's Haematology/Oncology Group

Phase 2 Terminated

Brain Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡